➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
McKinsey

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

ACEPHEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Acephen, and when can generic versions of Acephen launch?

Acephen is a drug marketed by Cosette and is included in four NDAs.

The generic ingredient in ACEPHEN is acetaminophen. There are sixty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.

US ANDA Litigation and Generic Entry Outlook for Acephen

A generic version of ACEPHEN was approved as acetaminophen by PERRIGO on February 25th, 2000.

  Start Trial

US Patents and Regulatory Information for ACEPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072218-001 Mar 27, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-003 Dec 18, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-001 Approved Prior to Jan 1, 1982 OTC No No   Start Trial   Start Trial   Start Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072344-001 Mar 27, 1992 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Harvard Business School
Boehringer Ingelheim
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.